FDA priority review status sends pSivida shares higher – BioMedReports (subscription) (blog)

posted on Aug 31 by in the Uncategorized category

FDA priority review status sends pSivida shares higher
BioMedReports (subscription) (blog)
... as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ...

and more »

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes